Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03364049 |
| Title | Study of MK-7162 in Combination With Pembrolizumab (MK-3475) in Adult Participants With Advanced Solid Tumors (MK-7162-002) |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme Corp. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ISR | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UCLA Medical Center ( Site 0002) | Santa Monica | California | 90404 | United States | Details | |
| START Midwest ( Site 0007) | Grand Rapids | Michigan | 49546 | United States | Details | |
| Laura and Isaac Perlmutter Cancer Center ( Site 0001) | New York | New York | 10016 | United States | Details | |
| Princess Margaret Hospital.. ( Site 0130) | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| Chaim Sheba Medical Center. ( Site 0301) | Ramat-Gan | 5265601 | Israel | Details | ||
| Severance Hospital Yonsei University Health System ( Site 0103) | Seoul | 03722 | Korea, Republic of | Details |